阿斯利康 AZN 深 滬
已收盤 12-12 16:00:00 美东时间
89.83
-0.460
-0.51%
華盛通- 最 高89.96
- 今 開89.40
- 成交量 537.73万股
- 最 低 89.28
- 昨 收 90.29
- 總市值 2785.63亿
- 52周最高 94.015
- 市盈率 靜 39.90
- 換手率 0.17%
- 52周最低 60.735
- 委 比 87.98%
- 總股本 31.01亿
- 歷史最高 94.015
- 量 比 0.90
- 振 幅 0.75%
- 歷史最低 3.59
- 每 手 1
- 風險率 7.56%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多FDA Weighs Black Box Warning For COVID Vaccines, Experts Push Back
FDA officials are weighing a black box warning for Covid vaccines, a proposal that has drawn strong criticism from outside experts citing lack of evidence.
12-13 02:51
GSK Expands Use Of Urinary Tract Infection Drug For Gonorrhoea Patients
GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments.
12-13 00:12
Pillar Biosciences与阿斯利康扩大液体活检准入合作关系至中国
Pillar Biosciences宣布，其与阿斯利康现有的基于NGS试剂盒的液体活检肿瘤分析实验室接入计划将扩展至中国市场。通过在中国领先临床实验室增加基于血...
12-12 16:20
Is the Market Bullish or Bearish on AstraZeneca PLC?
AstraZeneca PLC's (NYSE:AZN) short interest as a percent of float has fallen 6....
12-11 23:00
婴儿RSV疗法添变数！FDA启动对2款上市RSV单抗的安全性审查
（来源：抗体圈） 12月9日，据美联社报道，美国食品药品监督管理局（FDA）官员已对两种用于保护婴幼儿免受呼吸道合胞病毒（RSV）感染的长效RSV中和抗体药物展...
12-11 08:31
汇丰：上调多只欧洲医药股目标价
转自：财联社 【汇丰：上调多只欧洲医药股目标价】财联社12月10日电，汇丰银行将阿斯利康目标价从14640便士上调至16500便士；将葛兰素史克目标价从12...
12-10 14:22
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
AIM ImmunoTech Inc. has published a new CEO Corner segment on its website, where Chief Executive Officer Thomas Equels discusses the unmet need in pancreatic cancer and the Company’s lead program, Ampligen® (rintatolimod), which is currently being evaluated in the DURIPANC Phase 1b/2 clinical trial in combination with AstraZeneca’s Imfinzi® (durvalumab). For more details, visit the company’s website.
12-10 14:00
RSV shots for infants reportedly under FDA scrutiny
The Food and Drug Administration (FDA) has indicated plans to conduct a fresh review of currently marketed RSV treatments for infants following safety concerns raised by vaccine skeptics, Reuters repo...
12-09 22:12
